tiprankstipranks

Peter Wijngaard Insider Profile

4 Followers
Peter Wijngaard, CDO at Medicines Co, holds 9.50K shares in Hepion Pharmaceuticals (Ticker: HEPA), holds 0.00 shares in Medicines Co (Ticker: MDCO). Most recently, Peter Wijngaard Bought ― shares of Hepion Pharmaceuticals on Nov 28, 2023 for an estimated value of 15.35K.
tipranks
Peter Wijngaard

Peter Wijngaard
Medicines Co (MDCO)
CDO

Ranked #93,620 out of 99,335 Corporate Insiders

Profitable Transactions

0%
0 out of 4 Profitable Transactions

Average Return

-65.50%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$6K
100.00%
A breakdown of Peter Wijngaard's holdings

Insider Roles

Hepion Pharmaceuticals
(HEPA)
Director
Roles that Peter Wijngaard holds in companies

Most Profitable Insider Trade

Stock:
Hepion Pharmaceuticals
(HEPA)
Rating:Informative Buy
Date:Dec 21, 2020 - Dec 21, 2021
Return:-41.90%
The most profitable trade made by Peter Wijngaard

Peter Wijngaard's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
MDCO
Medicines Co
Jan 06, 2020
Uninformative Sell
$0.00
Hepion Pharmaceuticals
Nov 28, 2023
Director
Informative Buy
15.35K
$6.31K
List of latest transactions for each holding click on a transaction to see Peter Wijngaard's performance on stock

Peter Wijngaard insider profile FAQ

What is the percentage of profitable transactions made by Peter Wijngaard?
The percentage of profitable transactions made by Peter Wijngaard is 0%.
    What is the average return per transaction made by Peter Wijngaard?
    The average return per transaction made by Peter Wijngaard is -65.50%.
      What stocks does Peter Wijngaard hold?
      Peter Wijngaard holds: MDCO, HEPA stocks.
        What was Peter Wijngaard’s latest transaction?
        Peter Wijngaard latest transaction was an Informative Buy of $15.35K.
          What was Peter Wijngaard's most profitable transaction?
          Peter Wijngaard’s most profitable transaction was an Informative Buy of HEPA stock on December 21, 2020. The return on the trade was -41.90%.
            What is Peter Wijngaard's role in Medicines Co?
            Peter Wijngaard's role in Medicines Co is CDO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.